A Study of JNJ-64304500 in Participants With Alopecia Areata
Status:
Withdrawn
Trial end date:
2022-07-20
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the clinical response of 22 weeks of study
intervention with JNJ-64304500, compared with placebo, in participants with moderate to
severe alopecia areata (AA).